TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Revenue

Annual figures by fiscal year, from SEC filings.

2018: $02019: $148.36M2020: $227.55M2021: $78.45M2022: $75.47M2023: $116.33M2024: $332.31M2025: $403.13M$403.13M
2018Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$403.13M+21.3%
2024$332.31M+185.7%
2023$116.33M+54.1%
2022$75.47M-3.8%
2021$78.45M-65.5%
2020$227.55M+53.4%
2019$148.36M—
2018$0—